Background: One of the major risk factors for cardiovascular disease in diabetes mellitus is dyslipidemia. It is characterised by high plasma triglyceride level, low HDL cholesterol level and increased level of small dense LDL-cholesterol particles. The prevalence of hypercholesterolemia is not increased in patients with diabetes mellitus, but mortality from coronary heart disease (CHD) increases with serum cholesterol levels, and lowering of cholesterol with drug therapy reduces diabetic patient’s cardiovascular risk. 

Methods: The cross sectional study was conducted on patients consisting of 100 (50 male and 50 female) known type 2 diabetes mellitus. Age, gender, duration of disease, body mass index (BMI) was recorded in all patients. Fasting blood glucose levels, total cholesterol, triglycerides, HDL, LDL, VLDL levels were measured using standard methods and recorded.

Results: The serum parameters TC, TG, HDL, LDL, and VLDL were significantly correlated to FBG levels in both diabetic and non-diabetic subjects. The variables were also significantly associated among each other in T2DM patients.

Conclusion: The present study provides evidence to suggest that lipid variables are associated with each other in T2DM patients among the population.

Keywords: Coronary heart disease, Type 2 diabetes mellitus, body mass index.

1. Gadi R, Samaha FF. Dyslipidemia in Type 2 diabetes mellitus. Curr Diabet Reports. 2007; 7:228- 34.
2. Atiba AS, Oparinde DP, Babatunde OA, NiranAtiba TA, Jimoh AK. Liver enzymes and lipid profile among type 2 diabetic patients in Osogbo, Nigeria. Greener J Med Sci. 2013; 3(5):174-8.
3. Zargar AH, Wani AI, Masoodi SR, Laway BA, Bashir MI. Mortality in diabetes mellitus-data from a developing region of the world. Diab Res Clinic 1999,43(1):67-4.
4. Parkhad S, Palve S. Early diagnosis of neuropathy in diabetic patients using nerve conduction studies. National J Physiol Pharm 2014; 4(2): 158.
5. Vittal V, Shankar V, Kutty K, Kumar SA. An interventional study of physical activity on HbAlC and VO2max in type 2 diabetes mellitus. Indian J Physiol Pharmacol. 2016; 60(1):76-81.
6. Kolhar U, Priyanka P. Study of serum lipid profile in type 2 diabetes mellitus patients and its association with diabetic nephropathy. Int J Adv 2017; 4(6):1513-6.
7. Haffner SM. Management of dyslipidemia in adults with diabetes. Diab Care. 1998;21(1):160-78.
8. Chehade JM, Gladysz M, Mooradian AD. Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management. Drugs. 2013;73(4):327-39.
9. Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrin Metab. 2009;5:150-9.
10. Summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001; 285:2486-97. Available at: https://www.ncbi.nlmnih.gov/pubmed/11368702
11. Pandya H, Lakhani JD, Dadhania J, Trivedi A. The prevalence and pattern of dyslipidemia among type 2 diabetic patients at rural based hospital in Gujarat, Indian J Clinic Pract. 2012; 22(12):36-44.
12. Dayakar E, Sree CS, Sanjay E. Study on the prevalence of dyslipidemia in type 2 diabetes mellitus. Int J Adv Med 2019; 6:786-9.
13. Singh G, Kumar AK. A study of lipid profile in type 2 diabetic Punjabi population. J Exerc Sci Physioth. 2012; 8(1):7.
14. Pathak LA, Shirodkar S, Ruparelia R, Rajebahadur Coronary artery disease in women. Indian Heart J. 2017; 69(4):532-8.
15. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. New Eng J Med. 1989; 321(10):641.
16. Abbey M, Owen A, Suzakawa M, Roach P, Nestel Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL ­receptor activity. Maturit. 1999;33(3):259-69.

Dr Tarunendra Kumar Mishra

Senior Resident, Department of Medicine, NSCB Medical College, Jabalpur, MP, India